Session 126-Poster Abstracts
HCV Epidemiology and Natural History
Tuesday, 2-4 pm; Poster Hall
      742

MTCT of HCV among HIV/HCV-co-Infected Women
Claudia Checa Cabot*1, S Stoszek2, J Quarleri3, S Ivalo1, M Peixoto4, M Losso1, J Pilotto5, H Salomon3, L Sidi6, and J Read7
1Hosp Gen de Agudos Jose Maria Ramos Mejia, Buenos Aires, Argentina; 2Westat, Rockville, MD, US; 3Ctr Nacional de Referencia para el SIDA, Univ de Buenos Aires, Argentina; 4Hosp Femina, Porto Alegre, Brazil; 5Hosp Geral de Nova Iguaçu and Lab de AIDS e Imunologia Molecular, Inst Oswaldo Cruz, Rio de Janeiro, Brazil; 6Hosp Federal dos Servidores do Estado, Rio de Janeiro, Brazil; and 7Natl Vaccine Prgm Office, Occupational Safety and Hlth Admin, DHHS, Washington, DC, US
      743

HCV Incidence in the SHCS: A Changing Epidemic
Gilles Wandeler*1,2, T Gsponer2, A Witteck3, O Clerc4, A Calmy5, H Günthard6, M Battegay7, B Enos8, F Hansjakob1, R Andri1, and the Swiss HIV Cohort Study
1Univ Hosp Bern, Switzerland; 2Univ of Bern, Switzerland; 3Cantonal Hosp, St Gallen, Switzerland; 4Univ Hosp Lausanne, Switzerland; 5Univ Hosp Geneva, Switzerland; 6Univ Hosp Zurich, Switzerland; 7Univ Hosp Basel, Switzerland; and 8Regional Hosp Lugano, Switzerland
      744 A Clustering Phenomenon of HCV-1a Strains from HIV-co-infected Patients Could Be Related to the Epidemics of HIV-BF: Buenos Aires, Argentina
Federico Bolcic*1,2, N Laufer1,2, L Jones2,3, and J Quarleri1,2
1Ctr Nacional de Referencia para el SIDA, Univ de Buenos Aires Facultad de Med, Argentina; 2Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina; and 3Estación de Fotobiología, Playa Unión, Chubut, Argentina
      745 Lower Liver-related Mortality in African American Women Co-infected with HIV and HCV
S Monika1, P Bacchetti1, A French2, M Nowicki3, M Glesby4, G Sharp5, S Gange6, H Minkoff7, M Plankey8, Marion Peters*1, and Women’s Interagency HIV Study
1Univ of California, San Francisco, US; 2CORE Ctr, Stroger Hosp of Cook County, Chicago, IL, US; 3Univ of Southern California, Keck Sch of Med, Los Angeles, US; 4Weill Cornell Med Coll, New York, NY, US; 5DAIDS, NIAID, NIH, Bethesda, MD, US; 6Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 7State Univ of New York Downstate Med Ctr, Brooklyn, US; and 8Georgetown Univ Sch of Med, Washington, DC, US
      746

Trends in HCV Infection, Liver Disease Severity, and Specific Treatment Modalities among HIV+ Patients: Madrid, Spain
Juan González-García*1, C Navarro San Francisco1, E Condes2, C Díez Romero3, C Quereda4, F Zamora1, P Miralles3, A Moreno4, E Barquilla5, J Berenguer3, and GESIDA 5707 Study Group
1Hosp La Paz, Inst for Hlth Res, Madrid, Spain; 2Hosp de Móstoles, Madrid, Spain; 3Hosp Gregorio Marañón, Madrid, Spain; 4Hosp Ramon y Cajal, Madrid, Spain; and 5Fndn SEIMC-GESIDA, Madrid, Spain
      747

Incidence and Predictors of All-cause Death, Liver-related Death, and AIDS in an Incident Cohort of HIV+ Patients with Cirrhosis Estimated by FIB-4 Score
S Digiambenedetto1, M Prosperi1, Emanuele Focà*2, M Colafigli1, F Maggiolo3, N Ladisa4, G Lapadula5, A Pan6, N Marino7, C Torti2, and MASTER Cohort Study Group
1Catholic Univ of the Sacred Heart, Rome, Italy; 2Univ of Brescia, Italy; 3Ospedali Riuniti, Bergamo, Italy; 4Policlinico di Bari, Italy; 5San Gerardo Hosp, Monza, Italy; 6Istituti Ospedalieri, Cremona, Italy; and 7SM Annunziata Hosp, Florence, Italy
      748 Prediction of the Risk of Progression, Advanced Liver Fibrosis in HIV/HCV-co-infected Patients: The Ariadne Index
Pablo Barreiro*, F Rick, F Blanco, C de Burgos, E Vispo, P Labarga, JV Fernandez-Montero, and V Soriano
Hosp Carlos III, Madrid, Spain
      749

Impact of HIV/HCV Co-infection on Mortality of Patients with Alcohol Use Disorders
A Sanvisens1, F Bolao2, D Fuster1,3, S Pérez-Hoyos4, I Rivas5, J Tor1, and Robert Muga*1
1Hosp Univ Germans Trias i Pujol and Univ Autònoma de Barcelona, Badalona, Spain; 2Hosp de Bellvitge, Hosp de Llobregat, Univ de Barcelona, Spain; 3Boston Univ Sch of Med, MA, US; 4Inst de Recerca Hosp Vall d`Hebron, Univ Autònoma de Barcelona, Spain; and 5Municipal Ctr for Substance Abuse Treatment, Badalona, Spain
      750 The Effect of IL-2 in HIV-1 Patients with HBV/HCV Co-infection. Associations between Fibrosis Biomarkers at Baseline and Clinical Outcomes: The ESPRIT Study
Lars Peters*1, S Bhagani2, for the INSIGHT ESPRIT Study Group
1Copenhagen HIV Prgm, Univ of Copenhagen, Denmark and 2Royal Free Hosp, London, UK